#samsung bioepis

Collection of samsung bioepis news, found 4 news.

ATLATL and Samsung Bioepis Launch 'Samsung Bioepis Innovation Prize C-Lab

ATLATL and Samsung Bioepis Launch 'Samsung Bioepis Innovation Prize C-Lab

  • 30th June 2026

 ATLATL Innovation Center ("ATLATL"), a global innovation platform for life science research and ...

Samsung Bioepis Launches Ustekinumab Biosimilar, Marking Its First Product Launch in Japan

Samsung Bioepis Launches Ustekinumab Biosimilar, Marking Its First Product Launch in Japan

  • 20th May 2026

-Samsung Bioepis Co., Ltd. today announced the launch of Ustekinumab BS 45 mg Syringe for S.C. ...

Samsung Bioepis enters the European biopharmaceutical market with Benepali®, the first fusion protein biosimilar approved by the European Commission

Samsung Bioepis enters the European biopharmaceutical market with Benepali®, the first fusion protein biosimilar approved by the European Commission

  • 18th January 2016

- Samsung Bioepis Co., Ltd. today announced the European Commission’s (EC) approval of Benepali® – a ...

Samsung Bioepis' RENFLEXIS® Infliximab Biosimilar Receives Regulatory Approval in Korea

Samsung Bioepis' RENFLEXIS® Infliximab Biosimilar Receives Regulatory Approval in Korea

  • 4th December 2015

- Samsung Bioepis Co., Ltd. today announced that Korea’s Ministry of Food and Drug Safety (MFDS) has approved ...